Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients - Takeaways - MDSpire

Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients

  • By

  • Jennifer Erley

  • Julia Breckow

  • Kevin Roedl

  • Ann-Kathrin Ozga

  • Alidan Duoerkongjiang

  • Geraldine de Heer

  • Niklas Schubert

  • Fabian Pallasch

  • Christoph Burdelski

  • Stefan Kluge

  • Jin Yamamura

  • Gerhard Adam

  • Isabel Molwitz

  • August 6, 2025

  • 0 min

Share

  • 1

    Liver diseases in ICU patients have risen, leading to increased morbidity and mortality due to conditions like liver steatosis.

  • 2

    Dual-energy CT (DECT) provides a reliable method for quantifying liver fat content without interference from contrast agents.

  • 3

    The study aims to assess changes in liver fat fraction (FF) over time and its prognostic value in critically ill patients.

  • 4

    Liver biopsy is not recommended for critically ill patients due to bleeding risks, making imaging techniques essential for diagnosis.

  • 5

    Ultrasound is the first-line imaging test for liver steatosis, but DECT offers improved accuracy and reliability in ICU settings.

Original Source(s)

Related Content